SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Valeant Under Fire Again Following New York Times Article
October 5, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Pharm Country
Pfizer, Merck & Co., Valeant All Increase Prices of Existing Drugs
October 5, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Valeant Calms Employee Concerns of 20% Stock Drop As Congress Threatens Subpoena Over Drug Pricing
September 29, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Serial Acquirer Valeant Buys Synergetics USA in Sixth Deal of the Year (So Far)
September 2, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
AstraZeneca PLC Inks $445 Million Psoriasis Drug Pact With Valeant After Amgen Bows Out
September 1, 2015
 · 
2 min read
Job Trends
Valeant Doubles New Jersey Footprint on Heels of M&A Deals
August 26, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Valeant Acquires Female Sex Drive Drug Maker Sprout for $1 Billion
August 20, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Serial Acquirer Valeant Buys Egyptian Amoun for $800 Million
July 17, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
No Worries, Bayer Snubs Zoetis But Valeant Still Looking
July 2, 2015
 · 
4 min read
Load More
IN THE PRESS
Why Valeant Execs Could Learn A Lot from Allergan
March 29, 2016
 · 
1 min read
Valeant Doubled the Price of a Drug that Helped Terminally Ill People Die
March 23, 2016
 · 
1 min read
Biotech Beach
Orexigen To Host Conference Call At 8:30 A.M. Eastern Time Today To Discuss Acquisition Of U.S. Rights To Contrave (naltrexone HCl / bupropion HCl extended release) And Central And Eastern Europe Distribution Agreement With Valeant
March 15, 2016
 · 
1 min read
Business
Valeant Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information
March 15, 2016
 · 
18 min read
Business
Orexigen Announces Commercialization And Distributorship Agreement With Valeant For Mysimba (naltrexone HCl / bupropion HCl prolonged release) For 18 Central And Eastern European Countries And Turkey
March 15, 2016
 · 
19 min read
Business
Investors Breathe Down Valeant’s Neck to Up Transparency and Beef Up Management to Regain Credibility
March 14, 2016
 · 
1 min read
Policy
Valeant And R&O Pharmacy End Litigation
March 10, 2016
 · 
1 min read
Business
Valeant Surrenders Seat to Pershing Square, Appoints Two New Members in Board Shakeup
March 9, 2016
 · 
1 min read
Valeant To Hold Conference Call On March 15, 2016
March 7, 2016
 · 
2 min read
Business
Valeant CEO Pearson’s Talk with Analysts Raise Investors’ Hopes, Stock Jumps
March 7, 2016
 · 
1 min read
Load More